CME Group reported a rise in first-quarter profit on Wednesday, as heightened market volatility drove investors to the ...

Inhibrx Biosciences has drawn interest from drugmakers including Merck & Co, Germany’s Merck KGaA and Japan's Ono ...

Drugmaker Merck & Co said on Wednesday it will partner with Google Cloud to build up its artificial intelligence capabilities ...

Shares in European chip and electrical equipment makers rallied on Wednesday as investors piled into stocks set to benefit ...

If tests are positive, the city will flush the lines and move to a boil order. After that, there will be more testing and, if ...

Amneal Pharmaceuticals has agreed to acquire biopharma firm Kashiv BioSciences in a cash-and-stock deal worth up ​to $1.1 billion that will expand the ‌drugmaker's biosimilars business. The deal will ...

Britain should brace for a rise in cyberattacks linked to hostile states, the head of the country's cybersecurity agency said ...

AT&T added more wireless subscribers than expected in the first quarter, benefiting from customers opting for the telecom ...

Top computer chip equipment maker ASML will not be a bottleneck for the industry, as it was early in the ​decade, its CEO ...

Congressional leaders are signaling renewed momentum on a long-delayed farm bill as pressure builds from agricultural groups ...

Debate over U.S. biofuel policy is intensifying ahead of the summer driving season as lawmakers weigh changes to blending ...

The Federal Aviation Administration is accelerating enforcement of drone regulations, a move that could have broad ...